194 related articles for article (PubMed ID: 18635758)
1. Glutathione S-transferase A1 genetic variants reduce busulfan clearance in children undergoing hematopoietic cell transplantation.
Johnson L; Orchard PJ; Baker KS; Brundage R; Cao Q; Wang X; Langer E; Farag-El Maasah S; Ross JA; Remmel R; Jacobson PA
J Clin Pharmacol; 2008 Sep; 48(9):1052-62. PubMed ID: 18635758
[TBL] [Abstract][Full Text] [Related]
2. Influence of glutathione S-transferase A1, P1, M1, T1 polymorphisms on oral busulfan pharmacokinetics in children with congenital hemoglobinopathies undergoing hematopoietic stem cell transplantation.
Elhasid R; Krivoy N; Rowe JM; Sprecher E; Adler L; Elkin H; Efrati E
Pediatr Blood Cancer; 2010 Dec; 55(6):1172-9. PubMed ID: 20672371
[TBL] [Abstract][Full Text] [Related]
3. Glutathione S-transferase polymorphisms are not associated with population pharmacokinetic parameters of busulfan in pediatric patients.
Zwaveling J; Press RR; Bredius RG; van Derstraaten TR; den Hartigh J; Bartelink IH; Boelens JJ; Guchelaar HJ
Ther Drug Monit; 2008 Aug; 30(4):504-10. PubMed ID: 18641537
[TBL] [Abstract][Full Text] [Related]
4. Glutathione S-transferase gene variations influence BU pharmacokinetics and outcome of hematopoietic SCT in pediatric patients.
Ansari M; Rezgui MA; Théoret Y; Uppugunduri CR; Mezziani S; Vachon MF; Desjean C; Rousseau J; Labuda M; Przybyla C; Duval M; Champagne M; Peters C; Bittencourt H; Krajinovic M;
Bone Marrow Transplant; 2013 Jul; 48(7):939-46. PubMed ID: 23292236
[TBL] [Abstract][Full Text] [Related]
5. Influence of GST gene polymorphisms on the clearance of intravenous busulfan in adult patients undergoing hematopoietic cell transplantation.
Kim SD; Lee JH; Hur EH; Lee JH; Kim DY; Lim SN; Choi Y; Lim HS; Bae KS; Noh GJ; Yun SC; Han SB; Lee KH
Biol Blood Marrow Transplant; 2011 Aug; 17(8):1222-30. PubMed ID: 21215809
[TBL] [Abstract][Full Text] [Related]
6. Incorporation of GSTA1 genetic variations into a population pharmacokinetic model for IV busulfan in paediatric hematopoietic stem cell transplantation.
Nava T; Kassir N; Rezgui MA; Uppugunduri CRS; Huezo-Diaz Curtis P; Duval M; Théoret Y; Daudt LE; Litalien C; Ansari M; Krajinovic M; Bittencourt H
Br J Clin Pharmacol; 2018 Jul; 84(7):1494-1504. PubMed ID: 29469189
[TBL] [Abstract][Full Text] [Related]
7. Population pharmacokinetic analysis of intravenous busulfan: GSTA1 genotype is not a predictive factor of initial dose in Chinese adult patients undergoing hematopoietic stem cell transplantation.
Sun Y; Huang J; Hao C; Li Z; Liang W; Zhang W; Chen B; Yang W; Hu J
Cancer Chemother Pharmacol; 2020 Feb; 85(2):293-308. PubMed ID: 31834435
[TBL] [Abstract][Full Text] [Related]
8. Effect of glutathione S-transferase genetic polymorphisms on busulfan pharmacokinetics and veno-occlusive disease in hematopoietic stem cell transplantation: A meta-analysis.
Kim MG; Kwak A; Choi B; Ji E; Oh JM; Kim K
Basic Clin Pharmacol Toxicol; 2019 Jun; 124(6):691-703. PubMed ID: 30511436
[TBL] [Abstract][Full Text] [Related]
9. Influence of GST polymorphisms on busulfan pharmacokinetics in Japanese children.
Nishikawa T; Yamaguchi H; Ikawa K; Nakayama K; Higashi E; Miyahara E; Abematsu T; Nakagawa S; Kodama Y; Tanabe T; Shigemi A; Shinkoda Y; Okamoto Y; Takeda Y; Kawano Y
Pediatr Int; 2019 Jun; 61(6):558-565. PubMed ID: 30963629
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetics of intravenous and oral busulfan in hematopoietic cell transplant recipients.
Abbasi N; Vadnais B; Knutson JA; Blough DK; Kelly EJ; O'Donnell PV; Deeg HJ; Pawlikowski MA; Ho RJ; McCune JS
J Clin Pharmacol; 2011 Oct; 51(10):1429-38. PubMed ID: 21135089
[TBL] [Abstract][Full Text] [Related]
11. GSTA1 Genetic Variants and Conditioning Regimen: Missing Key Factors in Dosing Guidelines of Busulfan in Pediatric Hematopoietic Stem Cell Transplantation.
Nava T; Rezgui MA; Uppugunduri CRS; Curtis PH; Théoret Y; Duval M; Daudt LE; Ansari M; Krajinovic M; Bittencourt H
Biol Blood Marrow Transplant; 2017 Nov; 23(11):1918-1924. PubMed ID: 28807770
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic behavior and appraisal of intravenous busulfan dosing in infants and older children: the results of a population pharmacokinetic study from a large pediatric cohort undergoing hematopoietic stem-cell transplantation.
Paci A; Vassal G; Moshous D; Dalle JH; Bleyzac N; Neven B; Galambrun C; Kemmel V; Abdi ZD; Broutin S; Pétain A; Nguyen L
Ther Drug Monit; 2012 Apr; 34(2):198-208. PubMed ID: 22406655
[TBL] [Abstract][Full Text] [Related]
13. Precision dosing of intravenous busulfan in pediatric hematopoietic stem cell transplantation: Results from a multicenter population pharmacokinetic study.
Ben Hassine K; Nava T; Théoret Y; Nath CE; Daali Y; Kassir N; Lewis V; Bredius RGM; Shaw PJ; Bittencourt H; Krajinovic M; Uppugunduri CRS; Ansari M
CPT Pharmacometrics Syst Pharmacol; 2021 Sep; 10(9):1043-1056. PubMed ID: 34453497
[TBL] [Abstract][Full Text] [Related]
14. Influence of GST gene polymorphisms on busulfan pharmacokinetics in children.
Ansari M; Lauzon-Joset JF; Vachon MF; Duval M; Théoret Y; Champagne MA; Krajinovic M
Bone Marrow Transplant; 2010 Feb; 45(2):261-7. PubMed ID: 19584821
[TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetics and pharmacodynamics of busulfan with GSTA1 polymorphisms in patients undergoing allogeneic hematopoietic stem cell transplantation.
Choi B; Kim MG; Han N; Kim T; Ji E; Park S; Kim IW; Oh JM
Pharmacogenomics; 2015; 16(14):1585-94. PubMed ID: 26419450
[TBL] [Abstract][Full Text] [Related]
16. Effect of genetic variants GSTA1 and CYP39A1 and age on busulfan clearance in pediatric patients undergoing hematopoietic stem cell transplantation.
ten Brink MH; van Bavel T; Swen JJ; van der Straaten T; Bredius RG; Lankester AC; Zwaveling J; Guchelaar HJ
Pharmacogenomics; 2013 Nov; 14(14):1683-90. PubMed ID: 24192117
[TBL] [Abstract][Full Text] [Related]
17. Body weight-dependent pharmacokinetics of busulfan in paediatric haematopoietic stem cell transplantation patients: towards individualized dosing.
Bartelink IH; Boelens JJ; Bredius RG; Egberts AC; Wang C; Bierings MB; Shaw PJ; Nath CE; Hempel G; Zwaveling J; Danhof M; Knibbe CA
Clin Pharmacokinet; 2012 May; 51(5):331-45. PubMed ID: 22455797
[TBL] [Abstract][Full Text] [Related]
18. Integration of modelling and simulation into the development of intravenous busulfan in paediatrics: an industrial experience.
Nguyen L
Fundam Clin Pharmacol; 2008 Dec; 22(6):599-604. PubMed ID: 19049661
[TBL] [Abstract][Full Text] [Related]
19. Influence of glutathione S-transferase A1 polymorphism on the pharmacokinetics of busulfan.
Kusama M; Kubota T; Matsukura Y; Matsuno K; Ogawa S; Kanda Y; Iga T
Clin Chim Acta; 2006 Jun; 368(1-2):93-8. PubMed ID: 16448639
[TBL] [Abstract][Full Text] [Related]
20. Pediatric patients undergoing hematopoietic stem cell transplantation can greatly benefit from a novel once-daily intravenous busulfan dosing nomogram.
Rhee SJ; Lee JW; Yu KS; Hong KT; Choi JY; Hong CR; Park KD; Shin HY; Song SH; Kang HJ; Lee H
Am J Hematol; 2017 Jul; 92(7):607-613. PubMed ID: 28370238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
